Saturday, April 30, 2005

Drug for heart failure increases mortality -- Spurgeon 330 (7498): 981 -- BMJ

Drug for heart failure increases mortality -- Spurgeon 330 (7498): 981 -- BMJ: "Drug for heart failure increases mortality
David Spurgeon


Patients with heart failure who were treated with the drug nesiritide to help them survive a crisis were 80% more likely to die in the month after treatment than were patients who had received traditional drugs for symptoms of acute heart failure. This was the finding of a US study published last week in JAMA ( 2005;293: 1900-5)[Abstract/Free Full Text].

The drug's manufacturer Scios, which is part of Johnson & Johnson, released a statement a day after the JAMA study appeared, saying 'labelling has been revised to include an expanded analysis of the mortality rates seen in pivotal trials of the congestive heart failure agent."

No comments:

Post a Comment